Research and Development of Energy-Saving and Renewable Energy Technologies
First written in FY2017. 8 of 27 entries say "Restated". Latest entry: FY2026.
2 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Research and development expenses for the current consolidated fiscal year were ¥18 million. The company developed an app that allows users to view drawing data using an AR function and distributed it to all employees.」
Research and development expenses increased from ¥13 million in the previous fiscal year to ¥18 million. In addition to thermal-fluid simulation, energy conservation, CO2 reduction and odor control, the company distributed an AR field-inspection app to all employees. - FY2026-H1Research and development expenses increasedAnnual report
「Research and development expenses for the current interim consolidated accounting period were ¥9 million. There were no material changes in the status of research and development activities during the period.」
Although it states that there were no material changes in the status of research and development activities, research and development expenses increased from ¥4 million in the same period of the previous year to ¥9 million. - FY2025AdvancedAnnual report
「The R&D division has pursued the creation of a comfortable environment with a low environmental burden, focusing primarily on developing energy-saving systems through its facilities construction business.」
The company continues research and development focused on energy conservation and CO2 emissions reduction, with research and development expenses increasing from ¥9.9 million in the previous fiscal year to ¥13.073 million. - FY2025-H1R&D expenses decreasedAnnual report
「Research and development expenses for the current interim consolidated accounting period were ¥4 million. There were no material changes in the status of research and development activities during the period.」
Although it states that there were no material changes in research and development activities, research and development expenses for the current interim consolidated accounting period are reported as ¥4 million. - FY2024R&D expenses decreasedAnnual report
「R&D expenses for the current consolidated fiscal year were ¥9 million. The main R&D activities during the current consolidated fiscal year are as follows.」
The company continues R&D on energy-saving renovations, CO2 emissions reductions, localized ventilation in care spaces and AR applications, among other areas, but R&D expenses decreased from ¥29 million in the previous fiscal year to ¥9 million. - FY2024-Q3Research and development expenses increasedAnnual report
「R&D expenses for the cumulative third quarter of the current consolidated fiscal period were ¥9 million. There have been no material changes in the status of R&D activities during the cumulative third quarter of the current consolidated fiscal period.」
While stating that there have been no material changes in its R&D activities, the company reports that R&D expenses increased from ¥6 million for the cumulative second quarter to ¥9 million. - FY2024-Q2R&D expenses: ¥6 millionAnnual report
「R&D expenses for the cumulative second quarter of the current consolidated fiscal period were ¥6 million. There have been no material changes in the status of R&D activities during the cumulative second quarter of the current consolidated fiscal period.」
While stating that there have been no material changes in the status of its R&D activities, the company reports R&D expenses of ¥6 million for the cumulative second quarter. - FY2024-Q1No R&D expensesAnnual report
「There were no R&D expenses during the cumulative first quarter of the current consolidated fiscal period. There have been no material changes in the status of R&D activities during the cumulative first quarter of the current consolidated fiscal period.」
While stating that there have been no material changes in the status of its R&D activities, the company reports no R&D expenses for the cumulative first quarter of the current consolidated fiscal period. - FY2023ReframedAnnual report
「R&D expenses for the current consolidated fiscal year were ¥29 million. The main R&D activities during the current consolidated fiscal year are as follows.」
R&D expenses increased from ¥18 million in the previous fiscal year to ¥29 million, with specific themes including thermal-fluid simulation, energy-saving renovations and proposals to reduce CO2 emissions, localized ventilation in care spaces and AR applications. - FY2023-Q3R&D expenses: ¥24 millionAnnual report
「R&D expenses for the cumulative third quarter of the current consolidated fiscal period were ¥24 million. There have been no material changes in the status of R&D activities during the cumulative third quarter of the current consolidated fiscal period.」
While stating that there have been no material changes in its R&D activities, the company reports R&D expenses of ¥24 million for the cumulative third quarter. - FY2023-Q2R&D expenses: ¥17 millionAnnual report
「R&D expenses for the cumulative second quarter of the current consolidated fiscal period were ¥17 million. There have been no material changes in the status of R&D activities during the cumulative second quarter of the current consolidated fiscal period.」
While stating that there have been no material changes in its R&D activities, the company reports R&D expenses of ¥17 million for the cumulative second quarter. - FY2023-Q1R&D expenses: ¥5 millionAnnual report
「R&D expenses for the cumulative first quarter of the current consolidated fiscal period were ¥5 million. There have been no material changes in the status of R&D activities during the cumulative first quarter of the current consolidated fiscal period.」
While stating that there have been no material changes in its R&D activities, the company reports R&D expenses of ¥5 million for the cumulative first quarter. - FY2022ReframedAnnual report
「R&D expenses for the current consolidated fiscal year were ¥18 million. The main R&D activities during the current consolidated fiscal year are as follows.」
R&D expenses were ¥18 million, with specific research themes including ventilation simulation for infection control, energy-saving renovations and proposals to reduce CO2 emissions. - FY2022-Q3R&D expenses: ¥15 millionAnnual report
「R&D expenses for the cumulative third quarter of the current consolidated fiscal period were ¥15 million. There have been no material changes in the status of R&D activities during the cumulative third quarter of the current consolidated fiscal period.」
While stating that there have been no material changes in its R&D activities, the company reports R&D expenses of ¥15 million for the cumulative third quarter. - FY2022-Q1R&D expenses: ¥7 millionAnnual report
「R&D expenses for the cumulative first quarter of the current consolidated fiscal period were ¥7 million. There have been no material changes in the status of R&D activities during the cumulative first quarter of the current consolidated fiscal period.」
While stating that there have been no material changes in its R&D activities, the company reports R&D expenses of ¥7 million for the cumulative first quarter. - FY2021-Q3Higher research and development expensesAnnual report
「R&D expenses for the cumulative third quarter of the current consolidated fiscal period were ¥25 million. There have been no material changes in the status of R&D activities during the cumulative third quarter of the current consolidated fiscal period.」
While stating that there have been no material changes in its R&D activities, the company reports R&D expenses of ¥25 million, up from ¥20 million in the previous cumulative quarter. - FY2021-Q2RestatedAnnual report
「R&D expenses for the cumulative second quarter of the current consolidated fiscal period were ¥20 million. There have been no material changes in the status of R&D activities during the cumulative second quarter of the current consolidated fiscal period.」
The company states that there have been no material changes in its R&D activities and reports R&D expenses of ¥20 million for the cumulative current quarter. - FY2020-Q3Higher research and development expensesAnnual report
「R&D expenses for the cumulative third quarter of the current consolidated fiscal period were ¥20 million. There have been no material changes in the status of R&D activities during the cumulative third quarter of the current consolidated fiscal period.」
While stating that there have been no material changes in its R&D activities, the company reports R&D expenses of ¥20 million for the cumulative third quarter. - FY2020-Q2RestatedAnnual report
「R&D expenses for the cumulative second quarter of the current consolidated fiscal period were ¥13 million. There have been no material changes in the status of R&D activities during the cumulative second quarter of the current consolidated fiscal period.」
The company states that there have been no material changes in its R&D activities and reports R&D expenses of ¥13 million for the cumulative current quarter. - FY2019-Q3RestatedAnnual report
「R&D expenses for the cumulative third quarter of the current consolidated fiscal period were ¥23 million. There have been no material changes in the status of R&D activities during the cumulative third quarter of the current consolidated fiscal period.」
The company states that there have been no material changes in its R&D activities and reports R&D expenses of ¥23 million for the cumulative current quarter. - FY2019-Q2RestatedAnnual report
「R&D expenses for the cumulative second quarter of the current consolidated fiscal period were ¥16 million. There have been no material changes in the status of R&D activities during the cumulative second quarter of the current consolidated fiscal period.」
The company states that there have been no material changes in its R&D activities and reports R&D expenses of ¥16 million for the cumulative current quarter. - FY2019-Q1RestatedAnnual report
「R&D expenses for the cumulative first quarter of the current consolidated fiscal period were ¥8 million. There have been no material changes in the status of R&D activities during the cumulative first quarter of the current consolidated fiscal period.」
The company states that there have been no material changes in its R&D activities and reports R&D expenses of ¥8 million for the cumulative current quarter. - FY2018RaisedAnnual report
「An investment budget of ¥5 billion has been set for R&D investment in Japan and overseas over the 3 years from fiscal 2018 to fiscal 2020.」
In addition to its policy of continuing R&D in energy-saving, renewable energy and other areas, the company explicitly includes ¥5 billion in R&D investment in Japan and overseas in its 3-year investment budget. - FY2018-Q3RestatedAnnual report
「R&D expenses for the cumulative third quarter of the current consolidated fiscal period were ¥33 million. There have been no material changes in the status of R&D activities during the cumulative third quarter of the current consolidated fiscal period.」
The company confirms that there have been no material changes in its R&D activities and reports R&D expenses of ¥33 million for the cumulative current quarter. - FY2018-Q2RestatedAnnual report
「There have been no material changes in the status of R&D activities during the cumulative second quarter of the current consolidated fiscal period.」
The company continues to state that there have been no material changes in its R&D activities. - FY2018-Q1RestatedAnnual report
「There have been no material changes in the status of R&D activities during the cumulative first quarter of the current consolidated fiscal period.」
The company states that there have been no material changes in its R&D activities. - FY2017First statedAnnual report
「The R&D division has pursued the creation of a comfortable environment with a low environmental burden, focusing primarily on developing energy-saving systems through its facilities construction business.」
The company describes R&D in environmental and energy-saving technologies, including airflow simulation, energy-saving diagnostics, geothermal energy use and next-generation agriculture.